journal article·2007-11

Correlation between heparin release and polymerization degree of organically modified silica xerogels from 3-methacryloxypropylpolysilsesquioxane

David Tebbe, Roger Thull, Uwe Gbureck

Acta Biomaterialia· Volume 3· Issue 6
Publisher page

Abstract

This work aimed to investigate the use of an organically modified porous silica matrix (poly(methacryloxypropyl)-poly(silsesquioxane); P-MA-PS) as a release system for heparin. The matrices were obtained from methacryloxypropyltrimethoxysilane (MAS) via the sol-gel process under acidic conditions following photochemical polymerization and cross-linking of the organic matrix. Modulation of the polymerization degree of the organic matrix in the range 0-71% allowed adjusting the release kinetics of heparin according to therapeutic needs. It was demonstrated that higher drug loads and a decreasing polymerization degree resulted in a faster release profile of heparin, which followed a square root of time kinetic according to the Higuchi model. The hydrolytic degradation of hybrid xerogel was found to follow a zero-order kinetic whereas the heparin concentration did not show an influence on the degradation rate of the matrix. Since the released heparin retained its biological activity, the P-MA-PS matrices are of clinically interest, e.g. as coating on drug eluting coronary stents.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Silicone and Siloxane Chemistry · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantation10.1016/S0142-9612(02)00614-2 ↗
2. Experimental and pharmacokinetic studies with gentamicin PMMA beads
3. Heparin-loaded zein microsphere film and hemocompatibility10.1016/j.jconrel.2005.03.014 ↗
4. Effectiveness of the concomitant use of Bivalirudin and drug-eluting stents10.1016/j.amjcard.2005.04.039 ↗
5. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials10.1161/01.CIR.103.15.1967 ↗
6. Photochemical immobilization of heparin, dermatan sulphate, dextran sulphate and endothelial heparan sulphate onto cellulose membranes for the preparation of athrombogenic and antithrombogenic polymers10.1016/0142-9612(94)90089-2 ↗
7. Effect of tanning agent on tissue reaction to implanted collagen sponge10.1016/0022-4804(83)90029-X ↗
8. A method for the quantitative modification and estimation of carboxylic acid groups in proteins10.1016/S0021-9258(18)95981-8 ↗
9. Fabrication of micropored elastomeric film-covered stents and acute-phase performances10.1002/jbm.a.10314 ↗
10. Heparin coating reduces encrustation of ureteral stents: a preliminary report10.1016/S0924-8579(02)00097-3 ↗
11. The anticoagulant activity of derivatized and immobilized heparins10.1021/ba-1982-0199.ch012 ↗
12. Immobilized heparin: spacer arm effects on biological interactions10.1016/0049-3848(82)90149-9 ↗
13. Assessment of acrylic bone cement as a local delivery vehicle for the application of non-steroidal anti-inflammatory drugs10.1016/S0142-9612(98)00012-X ↗
14. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices10.1016/S0142-9612(00)00115-0 ↗
15. UV curable hard coatings on plastic10.1016/S0040-6090(99)00339-9 ↗
16. Biodegradation and biocompatibility of PLA and PLGA microspheres10.1016/S0169-409X(97)00048-3 ↗
17. Bond strength of silicoated and acrylic resin bonding systems to metal
18. Resin–metal bonding systems: a review of the silicoating and Kevloc systems
19. Modified PMMA-cements for a hydrolysis resistant metal–polymer interface in orthopaedic applications10.1016/j.actbio.2005.07.006 ↗
20. Preparation and characterization of organic–inorganic hybrids and coating films from 3-methacryoxypropylpolysilsesquioxane10.1002/aoc.213 ↗
21. Preparation and properties of silicon-containing polymer hybrids from 3-methacryoxypropylpolysilsesquioxane10.1002/(SICI)1099-0739(199810/11)12:10/11<749::AID-AOC782>3.0.CO;2-2 ↗
22. Aerogels airy materials: chemistry, structure, and properties
23. In vitro release of heparin from silica xerogels10.1016/S0142-9612(00)00407-5 ↗
24. Silica xerogels as a delivery system for the controlled release of different molecular weight heparins10.1007/s00216-004-2765-0 ↗
25. Gramble · 1967
26. Colorimetric method for the assay of heparin content in immobilized heparin preparations10.1016/0003-2697(80)90679-X ↗
27. Preparation and surface characterization of functional and heparin-immobilized polyurethanes by plasma glow discharge10.1016/0142-9612(96)81422-0 ↗
28. 1984 · 629
29. Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238)10.1016/0049-3848(78)90016-6 ↗
30. Tissue reactions to controlled release silica xerogel carriers
31. Silica xerogel as an implantable for controlled drug delivery – evaluation of drug distribution and tissue effects after implantation10.1016/S0142-9612(99)00148-9 ↗
32. Molecular design of alkoxide precursors for the synthesis of hybrid organic inorganic gels10.1016/S0022-3093(05)80584-8 ↗
33. Fourier-transform infrared-analysis of degree of polymerization in unfilled resins – methods comparison10.1177/00220345840630081901 ↗
34. Determination of resin cure using infrared analysis without an internal standard10.1016/0109-5641(94)90076-0 ↗
35. Brinker · 1990
36. Preparation and dental properties of polymeric dental restorative composites using oligoethyleneglycol diluent system
37. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems10.1016/S0168-3659(01)00248-6 ↗
38. Rate of release of medicaments from ointment bases containing drugs in suspension10.1002/jps.2600501018 ↗
39. Mechanism of sustained-action medication10.1002/jps.2600521210 ↗
40. Silica xerogel carrier material for controlled release of toremifene citrate10.1016/S0378-5173(99)00403-2 ↗
41. Constructing thromboresistant surface on biomedical stainless steel via layer-by-layer deposition anticoagulant10.1016/S0142-9612(03)00363-6 ↗